MODIFICATION
65 -- Central_Venous_Catheters
- Notice Date
- 11/4/2013
- Notice Type
- Modification/Amendment
- NAICS
- 339112
— Surgical and Medical Instrument Manufacturing
- Contracting Office
- Defense Logistics Agency, DLA Acquisition Locations, DLA Troop Support - Medical, 700 Robbins Avenue, Philadelphia, Pennsylvania, 19111-5096, United States
- ZIP Code
- 19111-5096
- Solicitation Number
- ME-1202-29
- Archive Date
- 11/23/2013
- Point of Contact
- Mr. Tom Winkel, Phone: 011-49-6371-9464-4089, Mr. Rob Halliday, Phone: 011-49-6371-9464-4090
- E-Mail Address
-
thomas.p.winkel.ctr@mail.mil, robert.b.halliday2.ctr@mail.mil
(thomas.p.winkel.ctr@mail.mil, robert.b.halliday2.ctr@mail.mil)
- Small Business Set-Aside
- N/A
- Description
- The Defense Medical Materiel Program Office (DMMPO) Medical Materiel Enterprise Standardization Office (MMESO) and the Defense Logistic Agency (DLA) Troop Support Medical Prime Vendor (PV) Program announce a Sources Sought Notification for the creation of a Qualified Suppliers Listing (QSL) for Central Venous Catheters. This is not a request for quote or proposal. The MMESO Europe is the lead MMESO for this project. These Central Venous Catheters products are for purchase by the Military Treatment Facilities (MTFs) of the Military Health System (MHS) and for the operational assemblages of the Army, Navy, Air Force, Marine Corps, and Naval Expeditionary Medical Support Command (NEMSCOM) and managed regionally by MMESOs North, South, West, Pacific and Europe, hereafter referred to as MMESOs. For information regarding DLA Troop Support Medical's PV program please access its web site at https://www.medical.dla.mil This Sources Sought notification is intended to solicit information and products for evaluation in order to create a QSL in accordance with (IAW) FAR 9.2 for Central Venous Catheters. All items proposed to be included in this QSL must be on DAPA for the DLA Troop Support Medical/Surgical Prime Vendor (MSPV) Program. The MSPV Program requires that all items be manufactured in a Trade Agreements Act Compliant Country (as defined by FAR 52.225-5), unless it is determined that no functionally equivalent item is available from a compliant source. To be eligible for inclusion in the proposed QSL, all vendors are required to complete the DAPA TAA Certification. Any questions concerning TAA may be directed to Bill Woltjen at DLA Troop Support, William.woltjen@dla.mil, 215-737-7124. The QSL for Central Venous Catheters will be established approximately February 2014 and is anticipated to be the basis of a Standardization Action. Qualified vendors will be invited approximately March 2014 to submit pricing proposals to enter into an Incentive Agreement for Central Venous Catheters. The government reserves the right to standardize or not standardize on Central Venous Catheters. A. Products & Performance Required. The MMESOs are seeking product line items in the category of Central Venous Catheters. Within the MHS MTFs and operational procurement this product line has an estimated annual sales volume of $1,036,176.66. This forecast is based on historical usage data during a recent 12-month period. Eighty-five product groupings were found to be relevant to the scope of this standardization action. Of the eighty-five product groups, eighty-four represent the clinically significant product groups for the QSL. Of those eighty-four, six items are considered the requirements for addition to the QSL and account for 52.1% ($539,929.62) of the total volume in sales ($1,036,176.66). The specifications for this project are shown in "Requirements to Qualify for QSL" section below. B. Instructions to Vendors Vendors interested in qualifying for inclusion in the QSL must provide an e-mail response to this QSL FBO Sources Sought notification to the lead MMESO POCs below. The vendor's responses must include all detailed information requested in the "Requirements to Qualify for QSL" section below and must also include: (1) Company name and address; (2) Company POC (Name and Phone Number, Fax Number, and E-mail address); (3) Commercial and Government Entity (CAGE) Code; and (4) Identification of the Sources Sought notification to which the vendor is responding. Due to the potential for e-mail to be lost in transmission, from network security, etc., vendors are strongly encouraged to confirm with the lead MMESO their e-mail submission has arrived. Each submitting vendor is advised to confirm receipt; allowing adequate time for resubmission before the due date and time should a problem occur with the first submission. As part of the "Requirements to Qualify for QSL", vendors must complete and submit the QSL FBO Package Worksheet. Any vendor experiencing difficulty opening the Worksheet may contact the MMESO POCs. The MMESO POC will provide a Worksheet copy via an alternate method (fax, email or hard copy). Vendors that do not meet the deadline of COB 5:00 PM Eastern Standard Time (EST) on the date listed for closing in this QSL FBO Sources Sought notification will not be included in the lead MMESO's review to establish the instant QSL and thus will not be able to participate in the subsequent Standardization Action. C. Source Selection Procedures The MMESO Joint Product Review Board (JPRB) will serve as the forum for clinical recommendations for product selection and coordinate logistics efforts in support of DoD Components. The board is chaired by Designated Senior Logisticians (DSLs) and co-chaired by Designated Senior Clinicians (DSCs) in the MMESO Areas of Responsibility (AORs) and includes clinicians and logisticians for MTFs within each MMESO. The Clinical Advisory Committee (CAC) members are the deciding officials for this initiative. The MMESO DSLs and DSCs intend to review responses and evaluate products for selection to the QSL IAW FAR 9.2. Requirements to Qualify for QSL Central Venous Catheters requirements are outlined below. Complete answers and all supporting documentation must be provided with the vendor's submittal by the response date stated in this QSL FBO Sources Sought notification. A vendor who does not meet all of these requirements or who does not submit documentation to support these requirements as requested will not be qualified for the QSL. Vendors must provide responses to this Sources Sought notification via the QSL FBO Package Worksheet. 1. Vendor must have a Distribution and Pricing Agreement (DAPA) or be in the process of applying for a DAPA number for the product line listed. Vendor must provide their DAPA number or provide documentation and date the DAPA number was applied for. Vendors who do not continue to process application for a DAPA number will not be considered for continued participation. 2. Vendor must have an agreement with the current DoD Medical/Surgical Prime Vendor CARDINAL HEALTH, or must work with CARDINAL HEALTH to initiate an agreement. 3. Vendor must have an agreement with the current DoD Medical/Surgical Prime Vendor OWENS & MINOR, or must work with OWENS & MINOR to initiate an agreement. 4. Vendor must have a government issued Commercial and Government Entity (CAGE) Code assigned for products contained within the specific product group or be in the process of obtaining one. Vendors who previously had an active record in Central Contractor Registration (CCR) must validate that their account is Active in the System for Award Management (SAMs) and provide Cage Code. Vendors in the process of obtaining a Cage Code must provide documentation to support that they have registered in SAMs. Vendors who do not continue to process application for a Cage Code and/or a SAMs account, will not be considered for continued participation. See https://www.sam.gov/portal/public/SAM// 5. Vendor MUST provide the following items listed. Vendor must provide product catalog & literature for any items offered in response to this Sources Sought Notification. Vendor must submit the following information via FBO Package Worksheet for each offered product: Full item description, Distributor Part Number, Manufacturer Part Number, Manufacturer Name, and Number of eaches in Unit of Sale. Only ONE Vendor Part Number (PN) should be provided for each item/sample. Required Products Annual Usage in Units/Each Antimicrobial CVC 7FR 20 CML Triple Lumen Maximum Barrier Tray 1956 Antimicrobial CVC 7FR 20 CML Triple Lumen Full Procedure Tray 2757 CVC 7FR 20 CML Triple Lumen Full Procedure Tray 821 Antimicrobial CVC 7FR 15-16 CML Triple Lumen Maximum Barrier Tray 433 Heparinized CVC 7FR 20 CML Triple Lumen Full Procedure Tray 865 Antimicrobial CVC 7FR 15-16 CML Triple Lumen Full Procedure Tray 215 6. Vendor must provide latex free or latex safe Central Venous Catheters, and provide documentation to support this with initial submittal. 7. Vendor must provide sterile Central Venous Catheters and tray items and documentation to support this with initial submittal. 8. Vendor must provide single-use Central Venous Catheters and tray items and documentation to support this with initial submittal. 9. Vendor must provide Central Venous Catheter Full Procedure Trays which includes the following minimum items and documentation to support this with initial submittal: one-CVC (power injectable), one-introducer needle, one-nitinol guidewire, one-dilator (catheter specific), one-catheter 18g 2.5 inches over-20g-needle, one-prefilled 10 ml.9% normal saline luer-lock syringe/per lumen, one-injection cap(s) per lumen, one-5 ml ampule 1% Lidocaine, one-5 ml luer lock syringe, one-22g safety needle, one-25g safety needle, one-small sharps needle holder, one-orange tint 2% w/v chlorhexidine gluconate (CHG) with isopropyl alcohol (IPA) 70% v/v preparation 3 ml applicator (location: area of tray before opening the procedure contents area), one-68" x 72" with 4" fenestration and with perforation (assist removal of drape post procedure), two-2"x2" gauze sponges, five-4"x4" gauze sponges, one-disposable #11 safety scalpel, one-3-0 silk suture with curved needle, one-suture needle holder, one-catheter securement fastener, and one-CSR wrap. 10. Vendor must provide Central Venous Catheter Maximum Barrier Trays includes the following minimum items and documentation to support this with initial submittal: one-CVC (power injectable), one-introducer needle, one-nitinol guidewire, one-dilator (catheter specific), one-catheter 18g 2.5 inches over-20g-needle, one-prefilled 10 ml.9% normal saline luer-lock syringe/per lumen, one-injection cap(s) per lumen, one-5 ml ampule 1% Lidocaine, one-5 ml luer lock syringe, one-22g safety needle, one-25g safety needle, one-small sharps needle holder, one-orange tint CHG w/70% IPA 3 ml applicator (location: area of tray (cap and mask location) before opening the procedure contents area), two-2"x2" gauze sponges, five-4"x4" gauze sponges, one-disposable #11 safety scalpel, one-3-0, silk suture with curved needle, one-suture needle holder, one-catheter securement fastener, one-CSR wrap, one-disposable towel (absorbent), one-68" x 72" with 4" fenestration and perforation (assist removal of drape post procedure), one-bouffant cap, one-impervious gown (size large), and one-mask with eye shield. 11. Vendor must provide safety needles contained in the Central Venous Catheter trays and documentation to support this with initial submittal. 12. Vendor must provide safety scalpels contained in the Central Venous Catheter trays and documentation to support this with initial submittal. 13. Vendor must provide a safe storage area or device in the Central Venous Catheter trays that secures the introducer needle and documentation to support this with initial submittal. 14. Vendor must provide Central Venous Catheter trays that contain a 2% w/v CHG with IPA 70% v/v preparation for cutaneous antisepsis (see tray requirements 3ml skin asepsis applicator) and documentation to support this with initial submittal. 15. Vendor must provide supporting documentation identifying what chemical(s) are used as the antimicrobial/antiseptic agent for the antimicrobial catheters. 16. Vendor must provide supporting documentation identifying what part of the antimicrobial catheter contains the antimicrobial/antiseptic agent. 17. Vendor must provide Central Venous Catheters that have centimeter spacing markers from the distal tip to the proximal hub and documentation to support this with initial submittal. 18. Vendor must provide Central Venous Catheters which are radiopaque and documentation to support this with initial submittal. 19. Vendor must provide Central Venous Catheter trays that open without contaminating the sterile contents within the tray. 20. Vendor must provide Central Venous Catheters that retain a secure connection between the syringe and the catheter port (without any leaks or disconnection) after attempts to pull them apart. 21. Vendor MAY provide any or all of the additional items listed below, following the same format as for requirements number 5. Item Description Antimicrobial CVC 14FR 10-11.5 CML Dual Lumen Full Procedure Tray CVC 2.7FR 12 CML Pediatric Single Lumen Full Procedure Tray CVC 14FR 10-11.5 CML Dual Lumen Full Procedure Tray CVC 7FR 20 CML Dual Lumen Full Procedure Tray Antimicrobial CVC 14FR 10-11.5 CML Dual Lumen Maximum Barrier Tray Antimicrobial CVC 8.5FR 16 CML Quad Lumen Maximum Barrier Tray Heparin Antimicrobial CVC 7FR 20 CML Triple Lumen Maximum Barrier Tray Pediatric Antimicrobial CVC 4FR 8 CML Dual Lumen Full Procedure Tray CVC 7FR 20 CML Triple Lumen Basic Tray Pediatric CVC 5FR 15 CML Triple Lumen Full Procedure Tray Heparin Antimicrobial CVC 8.5FR 11 CML Triple Lumen Full Procedure Tray Antimicrobial CVC 10FR 15-20 CML Five Lumen Maximum Barrier Tray CVC 7FR 20 CML Triple Lumen Maximum Barrier Tray CVC 7FR 15-16 CML Triple Lumen Full Procedure Tray Antimicrobial CVC 8FR 20 CML Dual Lumen Full Procedure Tray Pediatric CVC 4FR 5 CML Dual Lumen Full Procedure Tray Pediatric CVC 5 FR 5 CML Dual Lumen Full Procedure Tray Pediatric CVC 5FR 12 CML Dual Lumen Full Procedure Tray Pediatric 4FR 8 CML Dual Lumen Full Procedure Tray CVC 4.8FR 30 CML Single Lumen Basic Tray Pediatric Antimicrobial 4FR 12 CML Dual Lumen Full Procedure Tray CVC 6FR 50 CML Single Lumen Full Procedure Tray Heparin Antimicrobial CVC Dual Lumen 8.5FR 16 CML Full Procedure Tray CVC 7FR 20 CML Triple Lumen Catheter only Pediatric Antimicrobial CVC 4FR 5CML Dual Lumen Full Procedure Tray CVC 7FR 16 CML Dual Lumen Full Procedure Tray Antimicrobial CVC 8FR 20 CML Dual Lumen Full Procedure Tray Pediatric CVC 2.7 FR 13 CML Single Lumen Full Procedure Tray Antimicrobial CVC 9FR 11 CML Triple Lumen Full Procedure Tray Pediatric CVC 4FR 8 CML Dual Lumen Full Procedure Tray Heparin Antimicrobial 7FR 20 CML CVC Triple Lumen Full Procedure Tray CVC 5-5.5FR 8 CML Triple Lumen Full Procedure Tray Antimicrobial CVC 4FR 13 CML Dual Lumen Full Procedure Tray Pediatric 2FR 30 CML Single Lumen Basic Tray Antimicrobial CVC 5FR 15CML Triple Lumen Full Procedure Tray CVC 4FR 13CML Dual Lumen Full Procedure Tray CVC 4.8FR 20 CML Single Lumen Full Procedure Tray Antimicrobial 8FR 16 CML Dual Lumen Full Procedure Tray Antimicrobial Pediatric 5.5FR 13 CML Triple Lumen Maximum Barrier Tray Antimicrobial Pediatric 5.5FR 13 CML Triple Lumen Maximum Barrier Tray Antimicrobial CVC 5FR 8CML Dual Lumen Full Procedure Tray Antimicrobial 8.5FR 20 CML Quad Lumen Maximum Barrier Tray CVC 7FR 16 CML Triple Lumen Catheter Only CVC 5.5FR 30 CML Triple Lumen Full Procedure Tray Antimicrobial CVC 5FR 12 CML Dual Lumen Full Procedure Tray CVC 8.5FR 30 CML Quad Lumen Basic Tray Pediatric Antimicrobial 5FR 5 CML Dual Lumen Full Procedure Tray CVC 5FR 16 CML Single Lumen Basic Tray Antimicrobial 5-5.5FR 8 CML Triple Lumen Full Procedure Tray Antimicrobial CVC 4.8FR 16 CML Single Lumen Full Procedure Tray Antimicrobial CVC 5FR 8 CML Dual Lumen Full Procedure Tray Pediatric Antimicrobial CVC 5FR 5 CML 14Triple Lumen Full Procedure Tray Pediatric Antimicrobial CVC 5.5FR 13 CML Triple Lumen Full Procedure Tray CVC 7FR 15-16 CML Single Lumen Catheter Only CVC 5FR 15 CML Triple Lumen Full Procedure Tray Antimicrobial CVC 4FR 13 CML Dual Lumen Maximum Barrier Tray Antimicrobial CVC 4.8FR 20 CML Single Lumen Full Procedure Tray CVC 7FR 20 CML Dual Lumen Full Procedure Tray CVC 4FR 5 CML Dual Lumen Full Procedure Tray CVC 4FR 12 CML Dual Lumen Full Procedure Tray Heparin Antimicrobial CVC 7FR 15-16 CML Triple Lumen Full Procedure Tray CVC 4FR 8 CML Dual Lumen Full Procedure Tray CVC 4.8FR 16 CML Single Lumen Full Procedure Tray Pediatric CVC 1.6FR 9 CML Single Lumen Full Procedure Tray Pediatric CVC 5FR 8CML Triple Lumen Full Procedure Tray CVC 8FR 20 CML Dual Lumen Full Procedure Tray Heparin CVC 12FR 16 CML Triple Lumen Full Procedure Tray Antimicrobial CVC 5FR 8CML Triple Lumen Full Procedure Tray CVC 5FR 20 CML Single Lumen Full Procedure Tray CVC 5FR 13 CML Dual Lumen Full Procedure Tray CVC 4FR 30 CML Dual Lumen Full Procedure Tray Antimicrobial CVC 5FR 5 CML Double Lumen Full Procedure Tray CVC 5.5FR 13 CML Triple Lumen Full Procedure Tray CVC 7FR 15-16 CML Triple Lumen Full Procedure Tray CVC 4.8FR 20 CML Single Lumen Full Procedure Tray Heparin CVC 3FR 8 CML Single Lumen Catheter Only Pediatric CVC 5FR 13 CML Dual Lumen Basic Tray CVC 4.8 FR 16 CML Single Lumen Basic Tray Evaluation After the lead MMESO receives all information required above, they will send each vendor making a complete and approved submission a written request to provide product samples to Clinical Product Team (CPT) members at the participating MTFs. MTF "Ship to Addresses" will be provided as part of the request. To ensure your eligibility to participate, all products required for evaluation must be shipped no later than 14 calendar days from issuance of the MMESO's request and must arrive at all designated MTFs no later than 5:00 PM MTF local time at delivery location, 30 calendar days from issuance of the MMESO's request. Any products received after that time and date will not be included in the Clinical Process Teams' (CPT) reviews to establish the instant QSL and to participate in the subsequent Standardization Action, but will be destroyed upon receipt. Vendor will provide only the following products for evaluation. The products will be provided at no cost to the government for products or delivery, and unused products will not be returned. Three (each - not cases) of the required items listed is to be provided as product samples to each of the evaluation sites as requested by the Lead MMESO. Vendor will be required to supply the same part number(s) submitted in the QSL FBO Package Worksheet. Items for Evaluation Antimicrobial CVC 7FR 20 CML Triple Lumen Maximum Barrier Tray There will be approximately 13 MTFs enterprise wide that will be evaluating products. Each evaluator will evaluate the vendor submissions in the Central Venous Catheters product line. The MMESO CPT will review the responses from the vendors and the results from the product evaluations and determine which vendors meet the requirements. A vendor who provides all requested information and meets the requirements will be selected for inclusion in the QSL. Vendors will be notified of whether they met or did not meet the QSL requirements by approximately February 2014. Points of Contact (POCs): Mr. Thomas Winkel, MMESO Europe Team Leader, thomas.p.winkel.ctr@mail.mil, (49) 6371-9464-4089; and Mr. Robert Halliday, MMESO Europe Clinical Analyst, robert.b.halliday2.ctr@mail.mil, (49) 6371-9464-4090. DLA Troop Support Medical Contracting Officer: Tara J. Perrien, tara.perrien@dla.mil (215) 737-8307.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/DLA/J3/DSCP-M/ME-1202-29/listing.html)
- Place of Performance
- Address: ERMC HQ, CMR 402 box 219, Dept G4, Bldg 3739, Rm 222, Landstuhl, Rhineland-Palatinate,, Non-U.S., APO 09180-, Germany
- Record
- SN03227817-W 20131106/131105001125-fce39ac4df57bf67c613e125b6baa584 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |